Impact of YOGA on the Quality of Life and Well-being of Heart Failure Patients
Recruiting · NCT06019169 · Interventional (participants receive a specific treatment) · Lead sponsor: Assistance Publique - Hôpitaux de Paris
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
Heart failure (HF) is a chronic disease that has a strong impact on quality of life and is often accompanied by anxiety and depression symptoms that can contribute to poor treatment compliance. The overall management of heart failure is currently part of the recommendations and, alongside drug therapy and electrical devices that can be proposed, lifestyle changes (diet, physical activity) can help improve well-being. and perhaps patient prognosis. Yoga is an ancient practice, known to improve the emotional and physical well-being of individuals. There is no formal medical contraindication to this practice, which can be perfectly adapted to the patient's condition. However, very few patients with heart failure practice yoga. A few randomized trials with small numbers as well as the combined analysis of several studies have shown the benefit of yoga in heart failure. The main objective of the research is to demonstrate the improvement in the quality of life induced by the regular practice of yoga in the management of stabilized chronic heart failure patients. Secondly, we will evaluate the effectiveness of regular yoga practice on improving the clinical condition of chronic heart failure patients.
Who can take part
Inclusion criteria
- Patient ≥18 years old
- Chronic heart failure patient defined by: Most recent LVEF ≤50% (regardless of measurement method)
- Stabilized (last episode of acute heart failure dating back more than a month) in NYHA stage I to III dyspnoea, ambulatory, discharged from hospital for \> 1 month
- Drug treatment optimized according to the judgment of the investigator
- Ability to participate in activities as proposed (remote or face-to-face)
- Patient affiliated with a social security scheme
- Written consent to participate
Exclusion criteria
- Patients who have practiced yoga regularly (\> once a month) in the six months prior to selection.
- Current pregnancy / lactation
- Etiology of heart failure: hypertrophic cardiomyopathy, restrictive heart disease or severe curable valve disease
- Severe renal impairment GFR\<25ml/min/1.73 m2 or on dialysis.
- Persons subject to legal protection measures (guardianship, curatorship)
- Person not "receptive" to the practice of yoga
- Participation in intervention research
Where it is running
1 location listed.
- Institut de Cardiologie, Centre Hospitalier Universitaire Pitié Salpêtrière (APHP), UPMC - Paris, France